Zobrazeno 1 - 10
of 76
pro vyhledávání: '"D. H. Blankenhorn"'
Autor:
D H Blankenhorn, Clinton N. Corder, Carolyn Knight-Gibson, P. Alaupovic, D M Kramsch, W. J. Mack, L LaBree, H. N. Hodis, L. Cashin-Hemphill
Publikováno v:
Arteriosclerosis and Thrombosis: A Journal of Vascular Biology. 14:1906-1913
To establish whether lovastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, exhibits a specific effect on apolipoprotein (apo) A- and apoB-containing lipoproteins, 63 subjects, a subset of the 270 Monitored Atheroscler
Autor:
Stanley P. Azen, P L Lee, Janice M. Pogoda, Robert H. Selzer, Wendy J. Mack, Anne M. Shircore, D H Blankenhorn
Publikováno v:
Arteriosclerosis and Thrombosis: A Journal of Vascular Biology. 12:348-356
The Cholesterol Lowering Atherosclerosis Study, a randomized angiographic clinical trial, demonstrated the beneficial effect of niacin/colestipol plus diet therapy on coronary atherosclerosis. Outcome was determined by panel-based estimates (viewed i
Autor:
S A Schaffer, M. E. Rosenfeld, A. B. Chandler, S. Glagov, W Insull, C. J. Schwartz, M Richardson, H. C. Stary, W. D. Wagner, D H Blankenhorn
Publikováno v:
Circulation. 85:391-405
Autor:
D. H. Blankenhorn
Publikováno v:
JAMA: The Journal of the American Medical Association. 263:1646-1652
Autor:
Paul L. Lee, Anne M. Shircore, D H Blankenhorn, C. Hagerty, Robert H. Selzer, Maria Siebes, S. P. Azen
Publikováno v:
Proceedings. Computers in Cardiology 1988.
The end-diastole is the optimum portion of the cardiac cycle for computerized analysis of coronary angiograms, since vessel movement is minimal and the vessels are relatively straight. Since it is frequently not possible to find suitable end-diastoli
Autor:
Howard N. Hodis, D H Blankenhorn
Publikováno v:
Arteriosclerosis and thrombosis : a journal of vascular biology. 14(2)
This review explores evidence for the reversibility of atherosclerosis and augmentation of angiography with non-invasive arterial wall imaging. Meta-analysis from coronary angiographic trials demonstrates that regression and stabilization are 1.5 to
Autor:
D. H. Blankenhorn, H. N. Hodis
Publikováno v:
Handbook of Experimental Pharmacology ISBN: 9783642784286
The weight of evidence from primary and secondary prevention clinical trials indicates that reduction of low-density lipoprotein cholesterol (LDLC) levels by diets, drugs, or other means can decrease the incidence of fatal and nonfatal myocardial inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::800b3207663d6f7bbac35a1ae297aa57
https://doi.org/10.1007/978-3-642-78426-2_8
https://doi.org/10.1007/978-3-642-78426-2_8
Autor:
D H, Blankenhorn
Publikováno v:
Atherosclerosis. 102(1)
Autor:
D H, Blankenhorn, H N, Hodis
Evidence for atherosclerosis reversal comes from studies in animals wherein atherosclerosis is induced and then allowed to regress, autopsy studies of starved humans, and angiographic studies testing antiatherosclerosis treatment. Animal models and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::67be262db64a0ba15b0eb1b1a533cbf3
https://europepmc.org/articles/PMC1022223/
https://europepmc.org/articles/PMC1022223/
Publikováno v:
The Journal of rheumatology. 20(4)
Lipid, lipoprotein, and apolipoprotein effects of hydroxychloroquine were studied in 18 female patients with systemic lupus erythematosus (SLE) with mild or inactive disease. Patients were case matched (200-400 mg hydroxychloroquine daily vs no hydro